• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Concerns About Coronavirus Disease-Related Collateral Damage for Patients With COPD.

作者信息

Press Valerie G, Gershon Andrea S, Sciurba Frank C, Blagev Denitza P

机构信息

Department of Medicine and Department of Pediatrics, University of Chicago, Chicago, IL.

Sunnybrook Health Sciences Centre, Toronto, ON, Canada.

出版信息

Chest. 2020 Sep;158(3):866-868. doi: 10.1016/j.chest.2020.05.549. Epub 2020 May 28.

DOI:10.1016/j.chest.2020.05.549
PMID:32473947
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7837125/
Abstract
摘要

相似文献

1
Concerns About Coronavirus Disease-Related Collateral Damage for Patients With COPD.对慢性阻塞性肺疾病患者与冠状病毒病相关附带损害的担忧。
Chest. 2020 Sep;158(3):866-868. doi: 10.1016/j.chest.2020.05.549. Epub 2020 May 28.
2
Key Highlights of the Canadian Thoracic Society's Position Statement on the Optimization of COPD Management During the Coronavirus Disease 2019 Pandemic.加拿大胸科学会关于2019年冠状病毒病大流行期间慢性阻塞性肺疾病管理优化的立场声明要点
Chest. 2020 Sep;158(3):869-872. doi: 10.1016/j.chest.2020.05.530. Epub 2020 May 16.
3
[Asthma and COPD management during the COVID-19 pandemic].[COVID-19大流行期间的哮喘与慢性阻塞性肺疾病管理]
Rev Med Suisse. 2020 May 6;16(692):933-938.
4
Covid-19 and COPD: A Personal Reflection.新冠病毒与慢性阻塞性肺疾病：个人反思
Int J Chron Obstruct Pulmon Dis. 2020 Apr 24;15:883-884. doi: 10.2147/COPD.S255101. eCollection 2020.
5
Clinical challenges in chronic obstructive pulmonary disease in patients who suffered SARS-CoV-2 infection.曾感染新型冠状病毒2（SARS-CoV-2）的慢性阻塞性肺疾病患者的临床挑战
Med Clin (Barc). 2020 Aug 28;155(4):162-164. doi: 10.1016/j.medcli.2020.04.015. Epub 2020 May 7.
6
[Medical management and prevention instruction of chronic obstructive pulmonary disease during the coronavirus disease 2019 epidemic].[2019冠状病毒病流行期间慢性阻塞性肺疾病的医疗管理与预防指导]
Zhonghua Jie He He Hu Xi Za Zhi. 2020 May 12;43(5):421-426. doi: 10.3760/cma.j.cn112147-20200227-00201.
7
Novel coronavirus(Covid19), Its renal manifestations, and complications.新型冠状病毒（新冠病毒19）、其肾脏表现及并发症。
Urol J. 2020 Sep 13;17(5):558-559. doi: 10.22037/uj.v16i7.6431.
8
COVID-19 Board: Our Multidisciplinary Cutaneous Oncology Tumor Board During the Coronavirus-19 Pandemic.COVID-19 病例讨论会：新冠疫情期间我们的多学科皮肤肿瘤病例讨论会
Dermatol Surg. 2020 Sep;46(9):1224-1225. doi: 10.1097/DSS.0000000000002568.
9
Colorectal cancer services during the COVID-19 pandemic.2019冠状病毒病大流行期间的结直肠癌医疗服务
Br J Surg. 2020 Jul;107(8):e255-e256. doi: 10.1002/bjs.11706. Epub 2020 May 22.
10
Impact of COVID-19 on Peripheral Arterial Disease Treatment.2019冠状病毒病对周围动脉疾病治疗的影响
Ann Vasc Surg. 2020 Aug;67:6-7. doi: 10.1016/j.avsg.2020.05.045. Epub 2020 Jun 2.

引用本文的文献

1
Process evaluation of a pragmatic, multicentre pilot Randomised Controlled Trial (RCT) in primary care: Tailored intervention for COPD and Co-morbidities by Pharmacists and Consultant Physicians (TICC PCP).一项初级保健中务实的多中心试点随机对照试验（RCT）的过程评估：药剂师和顾问医师针对慢性阻塞性肺疾病（COPD）及其合并症的定制干预（TICC PCP）
PLoS One. 2025 Jun 30;20(6):e0326178. doi: 10.1371/journal.pone.0326178. eCollection 2025.
2
Exploring Psychological Trends in Populations With Chronic Obstructive Pulmonary Disease During COVID-19 and Beyond: Large-Scale Longitudinal Twitter Mining Study.探索2019年冠状病毒病期间及之后慢性阻塞性肺疾病患者群体的心理趋势：大规模纵向推特挖掘研究
J Med Internet Res. 2025 Mar 5;27:e54543. doi: 10.2196/54543.
3
Recognizing risk factors associated with poor outcomes among patients with COVID-19.识别与 COVID-19 患者不良预后相关的风险因素。
Prog Cardiovasc Dis. 2023 Jan-Feb;76:3-11. doi: 10.1016/j.pcad.2023.01.006. Epub 2023 Jan 21.
4
SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13.SARS-CoV-2 感染气道细胞会导致强烈的病毒和细胞脱落，这两种传播机制都受 IL-13 的影响。
Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2119680119. doi: 10.1073/pnas.2119680119. Epub 2022 Mar 30.
5
Estimated cost-savings from optimizing use of inhaled medications for inpatients with obstructive lung disease.优化阻塞性肺疾病住院患者吸入性药物使用的成本节约估计。
J Asthma. 2023 Feb;60(2):323-330. doi: 10.1080/02770903.2022.2047718. Epub 2022 Mar 10.
6
Treating COPD Patients with Inhaled Medications in the Era of COVID-19 and Beyond: Options and Rationales for Patients at Home.在 COVID-19 时代及以后用吸入药物治疗 COPD 患者：居家患者的选择和理由。
Int J Chron Obstruct Pulmon Dis. 2021 Sep 28;16:2687-2695. doi: 10.2147/COPD.S332021. eCollection 2021.
7
The Impact of Non-Ophthalmic Factors on Intravitreal Injections During the COVID-19 Lockdown.新冠疫情封锁期间非眼科因素对玻璃体内注射的影响
Clin Ophthalmol. 2021 Aug 28;15:3661-3668. doi: 10.2147/OPTH.S314840. eCollection 2021.
8
The Impact of COVID-19 on Hospitalised COPD Exacerbations in Malta.新冠疫情对马耳他住院 COPD 加重的影响。
Pulm Med. 2021 Jun 23;2021:5533123. doi: 10.1155/2021/5533123. eCollection 2021.
9
Prognostic Factors in COVID-19 Patients With New Neurological Manifestations: A Retrospective Cohort Study in a Romanian Neurology Department.新型冠状病毒肺炎（COVID-19）伴有新发神经症状患者的预后因素：罗马尼亚某神经内科的一项回顾性队列研究
Front Aging Neurosci. 2021 Jun 17;13:645611. doi: 10.3389/fnagi.2021.645611. eCollection 2021.
10
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.全球慢性阻塞性肺疾病诊断、管理和预防倡议。2020 年 GOLD 科学委员会关于 COVID-19 和慢性阻塞性肺疾病的报告。
Am J Respir Crit Care Med. 2021 Jan 1;203(1):24-36. doi: 10.1164/rccm.202009-3533SO.

本文引用的文献

1
Aerosolization of COVID-19 and Contamination Risks During Respiratory Treatments.新冠病毒的雾化及呼吸治疗期间的污染风险
Fed Pract. 2020 Apr;37(4):160-163.
2
COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?新型冠状病毒肺炎与非甾体抗炎药和皮质类固醇治疗：我们是否应在临床环境中限制其使用？
Ecancermedicalscience. 2020 Mar 30;14:1023. doi: 10.3332/ecancer.2020.1023. eCollection 2020.
3
Telemedicine in the Era of COVID-19.新冠疫情时代的远程医疗
J Allergy Clin Immunol Pract. 2020 May;8(5):1489-1491. doi: 10.1016/j.jaip.2020.03.008. Epub 2020 Mar 24.
4
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
5
Improving the Affordability of Prescription Medications for People with Chronic Respiratory Disease. An Official American Thoracic Society Policy Statement.改善慢性呼吸道疾病患者的处方药可负担性。美国胸科学会官方政策声明。
Am J Respir Crit Care Med. 2018 Dec 1;198(11):1367-1374. doi: 10.1164/rccm.201810-1865ST.
6
Chronic obstructive pulmonary disease and socioeconomic status: a systematic review.慢性阻塞性肺疾病与社会经济地位：系统评价。
COPD. 2012 Jun;9(3):216-26. doi: 10.3109/15412555.2011.648030. Epub 2012 Apr 12.
7
Conditions for which onset or hospital admission is potentially preventable by timely and effective ambulatory care.通过及时有效的门诊护理，发病或住院有可能得到预防的病症。
J Health Serv Res Policy. 2000 Oct;5(4):222-30. doi: 10.1177/135581960000500407.